Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| SARC | rs17125310 | chr1:64157197 | C/G | 5.65E-5 | 258 | 32.6 | 28.53 | 9.47 | KM Plot |
| SARC | rs17138987 | chr16:6016046 | A/G | 2.64E-11 | 258 | 4.27 | 27.1 | 32.3 | KM Plot |
| SARC | rs17160866 | chr11:70279927 | G/A | 5.76E-6 | 247 | 31.97 | 35.67 | 18.8 | KM Plot |
| SARC | rs17177275 | chr12:4913712 | G/C | 0 | 251 | 33.9 | 25.7 | 0.57 | KM Plot |
| SARC | rs174750 | chr1:182431098 | G/T | 1.51E-7 | 255 | 31.1 | 36.27 | 6.72 | KM Plot |
| SARC | rs174843 | chr1:182449420 | G/T | 1.32E-7 | 258 | 30.93 | 35.77 | 6.72 | KM Plot |
| SARC | rs1839098 | chr16:35139485 | A/G | 1.81E-7 | 258 | 8.73 | 34.77 | 31.97 | KM Plot |
| SARC | rs184172684 | chr3:52970504 | C/CT | 2.42E-14 | 253 | 30.85 | 34.57 | 1.17 | KM Plot |
| SARC | rs1862045 | chr7:134023412 | A/G | 7.98E-5 | 252 | 32.4 | 30.93 | 21 | KM Plot |
| SARC | rs1862046 | chr7:134023524 | T/C | 4.48E-5 | 249 | 32.4 | 31.1 | 21 | KM Plot |
| SARC | rs1865837 | chr16:46655516 | C/G | 0 | 258 | 1.07 | 23.35 | 33.2 | KM Plot |
| SARC | rs1912484 | chr17:45443664 | C/G | 2.72E-5 | 253 | 19.97 | 34 | 31.97 | KM Plot |
| SARC | rs1912485 | chr17:45515678 | T/G | 9.98E-5 | 257 | 19.97 | 34 | 32.4 | KM Plot |
| SARC | rs1912486 | chr17:45515167 | A/G | 9.98E-5 | 257 | 19.97 | 34 | 32.4 | KM Plot |
| SARC | rs1918827 | chr16:86456113 | A/G | 0 | 258 | 32.4 | 30.72 | 1.07 | KM Plot |